15-Deoxy-l l-O-methylspergualin (MeDSG)is an analogue of 15-deoxyspergualin, which has potent immunosuppressive activity. The present study was designed to evaluate the in vitro effects of MeDSGon the functions of peripheral blood mononuclear cells (PBMC)and bone marrow cells derived from healthy volunteers. MeDSGfailed to suppress the proliferation of PBMCstimulated with mitogens. In the allogeneic mixed lymphocyte reaction, MeDSGstrongly suppressed both the proliferation of lymphocytes and the generation of alloreactive cytotoxic T lymphocytes, but did not affect the cytolytic activity of the established cytotoxic T lymphocytes. MeDSG had no effect on the cytolytic activity of natural killer cells. Concerning positive hematopoietic regulators, MeDSG had a slight enhancing effect on the release of granulocyte-macrophage colony-stimulating factor and a slight inhibitory effect on the release of interleukin-6 and granulocyte colony-stimulating factor from PBMCstimulated with mitogens. Significantly, MeDSGcompletely suppressed the colony formation of bone marrow cells in the presence of granulocyte colony-stimulating factor.
The novel immunosuppressant 15-deoxyspergualin (DSG)1} is a derivative of spergualin, which was initially developed as an antitumor agent.2) DSGwas reported to prolong allograft survival in experimental allotransplantation models.3~7) It has been difficult to conclusively investigate the in vitro effect of DSG, however, since it is easily and quickly hydrolyzed, and loses its activity in usual culture conditions.8) % lysis= experimental dpm-spontaneousdpm total dpm-spontaneous dpm xlOO MLRTest Responder PBMC(1 x 105 cells) were cocultured with an equal number of stimulator PBMC irradiated with 25 Gy ofX-ray in the 96-well plates in 0.2ml of the RPMI complete mediumwith or without MeDSG. The cells were cultured for 5 days; 37kBq of 3H-thymidine was added to each well for the last 16 hours of the incubation. After culture, the cells were harvested and 3H-thymidine incorporation was measured as above. The percentage of suppression was calculated using the following formula :
%suppression= 1 -experimental dpm control dpm xlOO Cell-mediated Lympholysis (CML) Assay PBMC (1 x 105cells/ml) as responder cells were cocultured with 1 x 105cells/ml of irradiated (25 Gy) stimulator PBMCin the RPMIcomplete medium for 5 days in the presence or absence ofMeDSG. After culture, the cells were harvested and used as effector cells. Target cells were prepared by culturing stimulator cells with 0.1% PHA for 2 days. The effector cells (3 x 105 cells/ml) were cultured with 1 x 105 cells/ml of 51Cr-labeled target cells for 4hours with or without MeDSG. After the 4-hour culture, the cell-free supernatant was collected and the released 51Cr was counted as above. The inhibitory effect of MeDSGon cytolytic activity was calculated from the mean of triplicate culture using the following formula: % inhibition= 1 -experimental dpm-spontaneousdpm xlOO total dpm-spontaneous dpm Production of Cytokines by PBMC PBMC were cultured at a concentration of 5 x 105 cells/ml in the RPMI complete medium for 72hours MAR. 1995 under stimulation with 0.1% PHAor 10/ig/ml LPS in the presence or absence of MeDSG. After the culture, the cell-free supernatant was collected and the amount of interleukin-6 (IL-6), granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF (GM-CSF)was measured using enzyme-immunoassay as previously described. 15 " 17) Cell viability was confirmed by trypan-blue dye exclusion.
Clonal Cell Assay
The colony formation of bone marrowcells was performed according to a previously described method.18)
Briefly, 2 x 105 bone marrow buffy coat cells were cultured in 1 ml of Iscove's modified Dulbecco medium containing 20% FCS, 0.88% methylcellulose in 35-mm petri dishes. Each dish was supplemented with either various concentrations of G-CSF (Kirin Brewing Co., Ltd., Kakogawa-shi, Japan) or MeDSG.Seven and 14 days after culture, the number of colony-forming unit in granulocyte (CFU-G) or in granulocyte/macrophage (CFU-GM)containing 20 or more cells were counted with an inverted microscope.
Statistical Analysis
Statistical analysis was performed by Student's t-test.
Results

Effect of MeDSGon Proliferation of PBMC
Stimulated with Mitogens
The mean 3H-thymidine incorporation was 7,132+ 740dpm in the non-stimulated culture, and 203,177+
4,300, 121,747+12,557 and 13,889+1,734dpm in the blastogenic responses with PHA, PWMand LPS, respectively; there was a significant difference (P<0.01) between the non-stimulated and each mitogen-stimulated groups. MeDSG at a concentration of 10/^g/ml enhanced the proliferation of PBMC stimulated with PWM,inducing an increase of 59% (Fig. 1) . In contrast, MeDSGhad almost no inhibitory effect on the proliferation of PBMCby PHA or LPS.
Effect of MeDSGon NK Activity MeDSGat concentrations of 1 and 10//g/ml had no effect on the lysis of K562 cells in the presence of the effectors (Table 1 ). This result shows that MeDSG exhibited neither a promotive nor a suppressive effect on NK activity. MeDSG also appeared to prevent the autolysis of K562 cells.
Effect of MeDSG in MLR Tests
MeDSG inhibited the proliferative responses of alloreactive lymphocytes in a dose-dependent manner (Fig. 2) . This inhibition was 52% and 71% at concentrations of 1 and 10 /ig/ml, respectively. Effect of MeDSGon Alloreactive CTL Generated in MLRTests The addition of MeDSG to the culture during the first 5 days of generation of alloreactive CTLresulted in a remarkable suppression of CTL generation (Fig. 3) . In contrast, MeDSG failed to suppress the ability of generated CTLto cause the lysis of target cells when added in the cytolytic phase of the last 4hours. Effect of MeDSGon Cytokine Production of PBMC Stimulated with Mitogens For PBMCcultured in the presence of PHA, MeDSG 10/ig/ml induced an increase of 24%in the release of GM-CSFand a decrease of 19%in the release of IL-6 with respect to the control culture without MeDSG (Fig.   4) . The release of IL-6 without PHAwas not affected by the addition of MeDSG (data not shown). MeDSG (10 /ig/ml) induced a moderate 29% decrease in the ability of LPS-stimulated PBMCto release G-CSF, which was Data are shownas the mean±SD of triplicate cultures. * P< 0.01 compared with the control culture in the allogenic MLR. PBMCobtained from one donor were cocultured" with the irradiated PBMCfrom another donor for 5 days. Thereafter, the generated effector cells were admixed with 51Cr-labeled stimulator cells and cultured for 4 hours. MeDSG was added to the culture either at the initiation of the 5-day culture (O) or at the cytolytic phase of the last 4-hour culture (à"). Data are shownas the mean+SD from triplicate cultures. Mean control release calculated by the formula %lysis = (spontaneous release/total release) x 100 was 15.2+2.4. *i><0.01 compared with the control culture in the initiation phase of CTL. only a small amount below 1 ng/ml. After culture, the trypan-blue dye exclusion test confirmed that cell viability was greater than 95%in each experiment. 
